‘Pfizer and AstraZeneca were ABANDONED, yet…': Sen Johnson drops bombshell on COVID vaccine injuries

Key Concepts

• Vaccine Injury Deniers: A term used to describe officials or individuals who dismiss or ignore reports of adverse health effects following COVID-19 vaccination.
• EUA (Emergency Use Authorization): A mechanism to facilitate the availability and use of medical countermeasures during public health emergencies.
• V-safe: A CDC-managed smartphone-based tool using text messaging and web surveys to provide personalized health check-ins after COVID-19 vaccination.
• Process 1 vs. Process 2/3: Refers to changes in the manufacturing methods used by Pfizer and Moderna, specifically regarding how mRNA was produced and the diluents used, which critics argue were not adequately compared or tested.
• VAERS (Vaccine Adverse Event Reporting System): A national early warning system to detect possible safety problems in U.S.-licensed vaccines.
• Plasmid DNA Contamination: Concerns regarding the presence of residual DNA fragments from the manufacturing process (using bacteria) in the final vaccine product.

---

1. Critique of the Approval Process and Safety Testing

The transcript highlights significant concerns regarding the lack of comprehensive testing during the pre-EUA (Emergency Use Authorization) phase. Dr. Jablonski testified that the following critical safety assessments were omitted:

• Drug-drug interactions
• Cardiovascular, central nervous system, and organ-specific toxicity
• Blood toxicity
• Genotoxicity and carcinogenicity

The speakers argue that the public did not receive the same product used in clinical trials due to unauthorized or poorly characterized changes in manufacturing processes (referred to as Process 2 and Process 3). Specifically, Pfizer allegedly switched from "Process 1" (used in trials) to "Process 2" (using bacterial plasmids) without conducting the required 250-patient comparative study to ensure safety and efficacy equivalence.

2. Vaccine Injury and Public Perception

The speakers emphasize that vaccine injuries are real and often ignored by regulatory bodies.

• Case Studies: The transcript cites the experiences of Bri Draffin and Stephanie Maledigari, who participated in clinical trials. Maledigari reportedly suffered severe mobility issues and required a feeding tube, which was documented by Pfizer as a "stomach ache." Draffin reportedly incurred significant medical debt, with minimal compensation offered by the manufacturer.
• Public Sentiment: A Rasmussen study is cited, noting that 28% of Americans believe they personally know someone whose death was caused by the COVID-19 injection, and 48% believe there are legitimate reasons to be concerned about vaccine safety.

3. Statistical Analysis and Mortality Claims

The speaker challenges the Commonwealth Fund’s claim that vaccines saved 3.2 million lives.

• Methodology Critique: The speaker uses "simple addition" to argue that mortality rates did not decrease as expected after the vaccine rollout.
• Data Points:
  • 2019 deaths: ~2.8 million.
  • 2021 (vaccine year) deaths: 3.5 million.
  • 2022 deaths: 3.3 million.
• Argument: The speaker contends that to reach the "3.2 million lives saved" figure, one would have to assume 5 million deaths would have occurred annually without the vaccine, which they label as "complete bunk."

4. V-safe and Adverse Event Tracking

The V-safe system is criticized for its design and implementation:

• Scope: It was designed to track subclinical findings rather than serious clinical outcomes like myocarditis or death.
• Findings: 7.7% of the 10 million users sought medical care after injection, and 25% reported missed work days. The speakers argue these figures are "unusually high" for a vaccine.
• Regulatory Failure: Dr. Jablonski suggests that even if users had reported every symptom, the "freight train" speed of the vaccine rollout would have proceeded regardless.

5. Manufacturing Irregularities

The discussion on manufacturing highlights a lack of regulatory oversight:

• Process Changes: Pfizer changed its diluent (Process 3) and mRNA production method (Process 2) without proper characterization.
• DNA Contamination: Reference is made to Kevin McKernan’s findings regarding massive amounts of residual DNA (above acceptable limits) in the vaccines.
• International Oversight: The European Medicines Agency (EMA) reportedly asked probing questions regarding these manufacturing irregularities but allegedly received "perfunctory" answers and was pressured to cease further inquiry.

Synthesis and Conclusion

The primary argument presented is that the COVID-19 vaccine rollout was characterized by a lack of rigorous safety testing, a failure to address manufacturing changes, and a systemic dismissal of vaccine-injured individuals. The speakers contend that the official narrative of "safe and effective" is contradicted by both the high rate of medical care sought by vaccine recipients and the failure of mortality rates to decline as predicted by mathematical models. The testimony calls for greater transparency, accountability for manufacturers, and an acknowledgment of the adverse events experienced by the public.